These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21774758)

  • 1. Cardiac calmodulin kinase: a potential target for drug design.
    Bányász T; Szentandrássy N; Tóth A; Nánási PP; Magyar J; Chen-Izu Y
    Curr Med Chem; 2011; 18(24):3707-13. PubMed ID: 21774758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel CaMKII inhibitor GS-680 reduces diastolic SR Ca leak and prevents CaMKII-dependent pro-arrhythmic activity.
    Lebek S; Plößl A; Baier M; Mustroph J; Tarnowski D; Lücht CM; Schopka S; Flörchinger B; Schmid C; Zausig Y; Pagratis N; Marchand B; Koltun DO; Hung WK; Ahmadyar S; Belardinelli L; Maier LS; Wagner S
    J Mol Cell Cardiol; 2018 May; 118():159-168. PubMed ID: 29614261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure.
    Sag CM; Wadsack DP; Khabbazzadeh S; Abesser M; Grefe C; Neumann K; Opiela MK; Backs J; Olson EN; Brown JH; Neef S; Maier SK; Maier LS
    Circ Heart Fail; 2009 Nov; 2(6):664-75. PubMed ID: 19919992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of cGMP-dependent protein kinase stimulates cardiac ATP-sensitive potassium channels via a ROS/calmodulin/CaMKII signaling cascade.
    Chai Y; Zhang DM; Lin YF
    PLoS One; 2011 Mar; 6(3):e18191. PubMed ID: 21479273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-conductance Ca
    Tenma T; Mitsuyama H; Watanabe M; Kakutani N; Otsuka Y; Mizukami K; Kamada R; Takahashi M; Takada S; Sabe H; Tsutsui H; Yokoshiki H
    Am J Physiol Heart Circ Physiol; 2018 Aug; 315(2):H262-H272. PubMed ID: 29631373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca
    Baier MJ; Klatt S; Hammer KP; Maier LS; Rokita AG
    J Mol Cell Cardiol; 2020 Jan; 138():212-221. PubMed ID: 31836540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias.
    Swaminathan PD; Purohit A; Hund TJ; Anderson ME
    Circ Res; 2012 Jun; 110(12):1661-77. PubMed ID: 22679140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CaMKII as a target for arrhythmia suppression.
    Mustroph J; Neef S; Maier LS
    Pharmacol Ther; 2017 Aug; 176():22-31. PubMed ID: 27742568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calm down when the heart is stressed: Inhibiting calmodulin-dependent protein kinase II for antiarrhythmias.
    Duan DD
    Trends Cardiovasc Med; 2015 Jul; 25(5):398-400. PubMed ID: 25910598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental antiarrhythmic targets: CaMKII inhibition - ready for clinical evaluation?
    Maier LS
    Curr Med Chem; 2014; 21(11):1299-307. PubMed ID: 23862619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-calmodulin dependent protein kinase II (CaMKII): a main signal responsible for early reperfusion arrhythmias.
    Said M; Becerra R; Valverde CA; Kaetzel MA; Dedman JR; Mundiña-Weilenmann C; Wehrens XH; Vittone L; Mattiazzi A
    J Mol Cell Cardiol; 2011 Dec; 51(6):936-44. PubMed ID: 21888910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of SR Ca
    Neef S; Mann C; Zwenger A; Dybkova N; Maier LS
    Basic Res Cardiol; 2017 Jul; 112(4):45. PubMed ID: 28612156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium/calmodulin-dependent kinase II regulation of cardiac ion channels.
    Bers DM; Grandi E
    J Cardiovasc Pharmacol; 2009 Sep; 54(3):180-7. PubMed ID: 19333131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca
    Onal B; Gratz D; Hund TJ
    Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1227-H1239. PubMed ID: 28842436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple downstream proarrhythmic targets for calmodulin kinase II: moving beyond an ion channel-centric focus.
    Anderson ME
    Cardiovasc Res; 2007 Mar; 73(4):657-66. PubMed ID: 17254559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of ATP-Sensitive Potassium Channel Surface Expression in Heart Failure Underlies Dysregulation of Action Potential Duration and Myocardial Vulnerability to Injury.
    Gao Z; Sierra A; Zhu Z; Koganti SR; Subbotina E; Maheshwari A; Anderson ME; Zingman LV; Hodgson-Zingman DM
    PLoS One; 2016; 11(3):e0151337. PubMed ID: 26964104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CaMKII inhibition has dual effects on spontaneous Ca
    Sadredini M; Haugsten Hansen M; Frisk M; Louch WE; Lehnart SE; Sjaastad I; Stokke MK
    Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H446-H460. PubMed ID: 34270372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias.
    Gonano LA; Sepúlveda M; Rico Y; Kaetzel M; Valverde CA; Dedman J; Mattiazzi A; Vila Petroff M
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):947-57. PubMed ID: 22009705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca2+/calmodulin-dependent protein kinase inhibition suppresses post-ischemic arrhythmogenesis and mediates sinus bradycardic recovery in reperfusion.
    Bell JR; Curl CL; Ip WT; Delbridge LM
    Int J Cardiol; 2012 Aug; 159(2):112-8. PubMed ID: 21392835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.